NTRR: Lab Analysis to Begin on Groundbreaking Contaminants Test

NTRR: Lab Analysis to Begin on Groundbreaking Contaminants Test

SARASOTA, Fla.--(BUSINESS WIRE)-- Neutra Corp. (OTCBB: NTRR), a provider of all-natural wellness solutions, announced today that it's working to finalize a laboratory agreement to begin analyzing a simple, affordable new system for testing nutraceutical concentrates for harmful contaminants.

Led by Dr. Richard C. Kaufman, the company's new head of research and development in the $42 billion nutraceuticals industry, NTRR is developing a disposable system for testing oils, butters, tinctures, resins and other concentrates derived from medical marijuana (MMJ) for contaminants. Before releasing and marketing the product, however, NTRR must perform qualitative analysis to determine its efficacy under a variety of lab conditions.

"Obviously, it's crucial that we prove this system works before releasing it into the marketplace," said NTRR CEO Sydney Jim. "There's nothing like this on the market today, which is why we have such high expectations for its performance. Rigorous lab analysis is the first step toward making it easier than ever before to ensure safe, potent cannabinoid extractions for MMJ patients everywhere."

As hundreds of thousands of patients in approved markets turn to more efficient MMJ delivery methods, extractions such as butane hash oil, cannabutter, isohash and others are rapidly increasing in popularity. However, imperfect production of these tinctures and oils can pose significant health risks. Many cannabis oils, for example, are extracted using potentially harmful substances such as butane. NTRR is developing an easy, disposable test that will help nutraceutical users determine if their customized remedies are pure and free of contaminants.

By providing innovative nutraceutical products and services such as new MMJ breakthroughs, Neutra Corp. plans to follow in the footsteps of other successful public companies including Cannabis Science, Inc. (OTCBB: CBIS), Medical Marijuana Inc. (OTCBB: MJNA) and Terra Tech Corp. (OTCBB: TRTC), delivering technological advancements in the cultivation and processing of cannabis in approved markets.

For more information on NTRR's initiatives, please visit www.neutracorp.com.

About Neutra Corp.

Neutra Corp. is a healthy lifestyle company that specializes in the development and marketing of natural wellness solutions, including cannabis-related products. For investing information and performance data, please visit www.neutracorp.com.

Notice Regarding Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success, either financial or strategic, is no guarantee of success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.

Neutra Corp.
Sydney Jim, 813-367-2041
President and CEO
info@neutracorp.com

KEYWORDS: United States North America Florida

INDUSTRY KEYWORDS:

The article NTRR: Lab Analysis to Begin on Groundbreaking Contaminants Test originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.